Invitae Corporation
NVTA
주식 순위
#35798
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
주가
$0.016
마지막 동기화: 2024-03-11
시가총액
$3.27M
변동 (1일)
-5.33%
변동 (1년)
5,233.33%
국가
US
거래 Invitae Corporation (NVTA)
카테고리
Healthcare
Invitae Corporation (NVTA)의 EPS
September 2023 기준 EPS TTM: $-5.38
Invitae Corporation의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-5.38입니다. 2022년 말에는 회사의 EPS가 $-13.18였으며, 이는 2021년의 EPS $-1.80와 증가입니다.
Invitae Corporation의 EPS 기록 (2016 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $-5.38 | -100.00% |
| 2023 | 0.00 | -100.00% |
| 2022 | $-13.18 | 632.22% |
| 2021 | $-1.80 | -59.73% |
| 2020 | $-4.47 | 68.05% |
| 2019 | $-2.66 | 37.11% |
| 2018 | $-1.94 | -26.79% |
| 2017 | $-2.65 | -12.25% |
| 2016 | $-3.02 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $18.62 | -446.10% |
US
|
|
| $5.65 | -205.02% |
US
|
|
| $-1.36 | -74.72% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -194.61% |
US
|
